Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Terlipressin Administration in Patients Undergoing Major Liver Resection: a Prospective Randomized Blinded Trial

NCT01921985 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.

NCT NCT01921985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01921985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Terlipressin Administration in Patients Undergoing Major Liver Resection: a Prospective Randomized Blinded Trial
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 2013
Completion date
March 31, 2018
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver failure, liver resection